Department of Emergency Medicine

Convalescent plasma doesn’t help severely ill COVID patients: study

A Vanderbilt clinical trial shows that convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover

Sex & race & door-to-ECG time

More than a third of patients presenting at the emergency department with a suspected heart attack have a “delayed” ECG measure of heart function, with Black patients, females and non-English speakers more likely to experience delays.

The TOWAR team includes, from left, Sadia Laghari, MLS(ASCP); Mayur Patel, MD, MPH; Ashley Panas, MD, MPH; Allan B. Peetz, MD, MPH; Christy Kampe MAcc, CCRP, CIP; and April Johnson.

Trauma study aims to improve survival for bleeding patients

Emergency Medicine and Trauma Surgery researchers at Vanderbilt University Medical Center are joining Vanderbilt LifeFlight in a Department of Defense (DOD)-funded clinical trial aimed at improving survival with resuscitation techniques used to keep patients alive after a traumatic injury.

Corey Slovis, MD, recently received the Lifetime Service Award from the Association of Academic Chairs of Emergency Medicine.

Slovis lauded by academic emergency medicine peers

Vanderbilt’s Corey Slovis, MD, has received the Lifetime Service Award from the Association of Academic Chairs of Emergency Medicine

Cody Stubblefield, RN, gives the first of two injections of an antibody combination to Caroline Davis to protect her from COVID-19.

Vanderbilt and CDC research shows third vaccine dose key to preventing omicron hospitalization

Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.

Donna Seger, MD

Tennessee Poison Center director Seger retires

1 2 3 4 6